Search results
18 paź 2024 · Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Read More About ASCO.
- Current Issue
CLINICAL TRIAL UPDATES Sep 11, 2024. Adjuvant Pertuzumab and...
- More Articles
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Flashback Foreword: Prognostic Factors in Osteosarcoma
This author is an Associate Editor for Journal of Clinical...
- Playing by Eye
Playing music by ear parallels a clinical oncology encounter...
- NeoSTEEP
PURPOSEThe Standardized Definitions for Efficacy End Points...
- Erratum
Journal of Clinical Oncology 2023 41: 31, 4941-4941 View...
- Phase IB Results
Journal of Clinical Oncology. Volume 41, Number 31 November...
- Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma
Journal of Clinical Oncology. Volume 41, Number 19 July...
- Current Issue
11 wrz 2024 · ORIGINAL REPORTS Jul 24, 2024. Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Priya Rastogi et al. full text abstract pdf Favorite. Supportive Care and Quality of Life.
1 paź 2024 · CLINICAL TRIAL UPDATES Sep 11, 2024. Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update. Sibylle Loibl et al. full text abstract pdf Favorite.
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research.
A peer-reviewed medical journal on clinical oncology, published by the American Society of Clinical Oncology. Learn about its history, editors, impact factor, and international editions.
1 paź 2024 · The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph ...
American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists. The emphasis of AJCO is on combined modality multidisciplinary loco-regional management of cancer.